Zura Bio Ltd (ZURA) stock
ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.93−0.02 (-2.30%)
Close on Nov 20, 2026Market cap $89.63MP/E –Yield –
Earnings
Zura Bio's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 18, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.20
-$0.21 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Zura Bio's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 18, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 27, 2026before the open | – | – | -$0.20 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 11, 2026before the open | – | – | -$0.21 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026before the open | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 19, 2026during market hours | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 13, 2025before the open | – | – | -$0.21 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025before the open | – | – | -$0.17 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025before the open | – | – | -$0.19 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 25, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 13, 2024before the open | – | – | -$0.17 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024before the open | – | – | -$0.02 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024before the open | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023during market hours | – | – | -$1.31 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Zura Bio has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Zura Bio puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Zura Bio filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Update
- Update
- Results
- Results
See a number that looks wrong?